טוען...
Probing RAS function with Monobodies
ii. RAS is frequently mutated in human cancers with nearly 27% of all cancers harboring mutations in one of three RAS isoforms (KRAS, HRAS or NRAS). Furthermore, RAS proteins are critical oncogenic drivers of tumorigenesis. As such, RAS has been a prime focus for development of targeted cancer thera...
שמור ב:
| הוצא לאור ב: | Methods Mol Biol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8121162/ https://ncbi.nlm.nih.gov/pubmed/33977484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-0716-1190-6_17 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|